SamuelJohnMaiserMD(He/Him)

Hospice and Palliative Medicine

Medical Director, Hennepin Healthcare ALS Center of Excellence

Dr. Maiser is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
715 S 8th St
Minneapolis, MN 55404
Phone+1 612-873-6963

Fax+1 612-873-1621

Dr. Samuel Maiser is a neurologist in Minneapolis, MN and is affiliated with Hennepin Healthcare. He received his medical degree from University of Minnesota Medical School and has been in practice 8 years. He specializes in neurophysiology and hospice and palliative medicine and is experienced in general neurology, electromyography, neuromuscular medicine, clinical neurophysiology, and hospice and palliative care.

PubMed

248 citations
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
Sabrina Paganoni, Eric A. Macklin, Suzanne Hendrix, James D. Berry, Michael A. Elliott
The New England Journal of Medicine. 2020-09-02
97 citations
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson, Newman Knowlton, Eric A. Macklin
Muscle & Nerve. 2021-01-01
22 citations
MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design.
Bjorn Oskarsson, Nicholas J. Maragakis, Richard Bedlack, Namita Goyal, Jenny A Meyer
Neurodegenerative Disease Management. 2021-11-24

Journal Articles

Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
Sabrina Paganoni, Michael A Elliott, Samuel Maiser, Margaret A Owegi, Stephen A Goutman, Carlayne E Jackson, Jeffrey D Rothstein, Edward J Kasarskis, Liberty Jenkins, ..., The New England Journal of Medicine